Oh dear, I suspect today's sell-off may be linked to poor communication around the launch timing for our smartwatch, which is end of FY Q3/start Q4 ( end of March, early April 2021). This has been referred to numerous times in many presentations. See below
However, in the quarterly activities report, it was mistakenly poorly communicated as :
No FDA clearance is required for the Company’s first wearable product launch in partnership with
Mobvoi – which is on track for Q4 2021.
IT IS Q4 of the FY 20/21, not the calendar year 2021.
As a result, this has been mis-represented in this *****head report published this morning :
https://*****head.com.au/health/medical-devices-tracker-all-the-life-saving-gadgets-asx-companies-are-working-on-right-now/
Anyone without in depth knowledge of CDX. reading this, can only assume it has been delayed.
I actually think Craig needs to re-inform the market of correct dates before things get out of hand.
Add to My Watchlist
What is My Watchlist?
